Palisade Bio, Inc. (PALI)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$1.49−$0.0812 (−5.17%) on the dayAs of the close; data may be delayed.
PALI price, last 12 months
Key stats
- Previous close
- $1.57
- Open
- $1.59
- Day range
- $1.45 – $1.60
- 52-week range
- $0.7000 – $2.86
- Volume
- 5.7M
- Avg volume (20 days)
- 3.3M
- Market cap
- $252.7M
Performance
1W−6.4%
1M−30.1%
3M−21.2%
6M−24.0%
YTD−36.7%
1Y+117.5%
vs S&P 500, 1Y+100.8 pts
Technicals and fundamentals
About Palisade Bio, Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $252.7M